Case Study: Global Pharmaceutical Company accelerates clinical trial decisions with Cloverpop

Accelerating Clinical Trial Decision-Making for Global Pharma

A global pharmaceutical company faced a complex and time-consuming process for deciding which developmental drugs to advance to clinical trials. Requiring input from six different functional groups, their inefficient coordination led to major delays and financial risk. To accelerate this high-stakes decision-making, they turned to Cloverpop for a solution using its collaboration platform.

Cloverpop developed a comprehensive decision playbook that established clear evaluation criteria and streamlined collaboration across all teams. This solution cut the time to make these critical decisions by 50%, saving the client an estimated $1.5 million and allowing them to capture market opportunities faster. The result was a more efficient pipeline and faster action to trial for promising drug candidates.